Periodic Reporting for period 1 - HEAL (HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart)

BackgroundThe project “HLA-homozygous iPSC-cardiomyocyte Aggregate manufacturing technologies for allogenic cell therapy to the heart” (HEAL) is focused on overcoming numerus hurdles to human induced pluripotent stem cell (iPSC)-based therapies to heart failure, which...